Unveiling Dopamine and Met-Enkephalin Dynamics: Simultaneous Co-Detection in Rat Striatum
Jenna M Berger1, Jovica Todorov2, Kalynn M Turner2
1Department of Chemistry, North Carolina State University, Raleigh, North Carolina 27695, United States.
Analytical Chemistry
|November 8, 2025
Summary
This study reveals that met-enkephalin (M-ENK), an endogenous opioid peptide, has a slower and more widespread release in the brain than dopamine, impacting distinct neural populations.
Area of Science:
- Neuroscience
- Neurochemistry
- Molecular Biology
Background:
- Endogenous opioid peptides (e.g., met-enkephalin) are crucial for pain perception and substance use disorders.
- Their transmission kinetics and spatial spread compared to small-molecule neurotransmitters like dopamine remain unclear.
Purpose of the Study:
- To directly compare the release kinetics and diffusion of dopamine and met-enkephalin (M-ENK) in the rat striatum.
- To investigate the release mechanisms and spatial influence of M-ENK.
Main Methods:
- Fast-scan cyclic voltammetry with carbon microelectrodes for simultaneous dopamine and M-ENK detection.
- Voltammetric waveform optimized for M-ENK sensitivity and minimal biofouling.
- Mathematical modeling and liquid chromatography-mass spectrometry for M-ENK verification.
Main Results:
- Both dopamine and M-ENK release scaled with stimulation duration.
- M-ENK exhibited a biphasic release profile with a ~30s latency, indicating a ~3x larger sphere of influence than dopamine.
- Evidence suggests co-release of M-ENK and extracellular generation from larger precursors.
Conclusions:
- Provides direct evidence for distinct release dynamics and spatial spread of neuropeptides versus small-molecule neurotransmitters.
- Demonstrates how dopamine and M-ENK can differentially modulate cellular populations in the striatum even when co-released.
